The Globe and Mail reports in its Friday edition that Scotia Capital analyst Jonathan Goldman has boosted his recommendation for ATS to "sector outperform" from "sector perform." The Globe's David Leeder writes in the Eye On Equities column that Mr. Goldman hiked his share target to $49 to $45. Analysts on average target the shares at $48.09. Mr. Goldman says in a note: "What turns us more bullish now is the nuclear backlog build and positive commentary on the call. Nuclear now accounts for 13 per cent of backlog ($275-million) and more than two times year ago levels ($110-million). Management noted the nuclear funnel continues to broaden beyond refurbishment, covering service and new nuclear reactor builds, including SMRs. We see downside risk to top-line estimates this year as company expectations for consolidated revenue growth of HSD [high single digits] are below consensus (and prior commentary which suggested HSD was organic alone). Tax-loss selling is also a risk, but we see no need to get cute here when thematic exposure is the play du jour." While Mr. Goldman cut his full-year 2026 and 2027 earnings expectations after acknowledging his previous revenue assumptions were "too aggressive relative to consensus."